Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MassmedicaWAR:MSM +2.27%84 Days Payable is 164.76 as of Mar. 2026, which is 23% below its 10-year median of 213.27. GuruFocus rates WAR:MSM with a GF Score™ of 84/100 and a GF Value™ of zł4.31 (Fairly Valued). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Massmedica ranks better than 79.62% on this metric.
Massmedica's average Accounts Payable for the
three
months ended in Mar. 2026 was zł8.13 Mil. Massmedica's Cost of Goods Sold for the
three
months ended in Mar. 2026 was zł4.50 Mil.
Hence, Massmedica's Days Payable for the
three
months ended in Mar. 2026 was 164.76.
The historical rank and industry rank for Massmedica's Days Payable or its related term are showing as below:
WAR:MSM'
s Days Payable Range Over the Past 10 Years
Min: 128.78 Med: 213.27 Max: 296.52
Current: 163.65
During the past 10 years, Massmedica's highest Days Payable was 296.52. The lowest was 128.78. And the median was 213.27.
WAR:MSM's Days Payable is ranked better than 79.62% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs WAR:MSM: 163.65
Massmedica's Days Payable
increased
from Mar. 2025 (134.37) to Mar. 2026 (164.76).
It may suggest that Massmedicadelayed paying its suppliers.
Massmedica Days Payable Related Terms
Massmedica Days Payable Historical Data
* Premium members only.
The historical data trend for Massmedica's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Massmedica's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Massmedica Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Massmedica's Days Payable distribution charts can be found below:
* The bar in red indicates where Massmedica's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Massmedica's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Massmedica (WAR:MSM) has a Days Payable of 164.76 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Massmedica and its competitors. This is 23% below median its historical median of 213.27. Over the past decade, Massmedica's Days Payable has ranged from 128.78 to 296.52. According to the industry distribution chart, Massmedica ranks #162 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 20.4%.
Is Massmedica's Days Payable too high?
Massmedica's current Days Payable of 164.76 is 23% below median its 10-year median of 213.27. Over the past 10 years, this metric has ranged from a low of 128.78 to a high of 296.52. The Medical Devices & Instruments industry median Days Payable is 67.87. Massmedica's value of 164.76 is 142.8% above this industry median. Based on the distribution chart, Massmedica ranks #162 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Massmedica has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Massmedica's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Massmedica ranks #162 out of 795 companies for Days Payable. This places Massmedica in the top 20% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. Massmedica's value of 164.76 is 142.8% above this benchmark. Historically, Massmedica's own Days Payable has ranged from 128.78 to 296.52 over the past decade. While the company's 10-year median is 213.27 vs. the industry median of 67.87, Massmedica has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Massmedica's current Days Payable of 164.76 is 142.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Massmedica and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Massmedica's current Days Payable is 164.76, which is 23% below median its own 10-year median of 213.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Massmedica stock overvalued right now?
Based on GuruFocus' analysis, Massmedica (WAR:MSM) is currently considered Fairly Valued. The stock's GF Value™ is zł4.31, compared to a current price of zł4.50 — trading 4.4% above its estimated fair value. The current Days Payable is 164.76, which is 23% below median its 10-year median of 213.27 and 142.8% above the Medical Devices & Instruments industry median of 67.87. Massmedica's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Massmedica (WAR:MSM), the current Days Payable is 164.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Massmedica (WAR:MSM) Overvalued in 2026?
Based on GuruFocus' analysis, Massmedica stock appears to be overvalued.
The current stock price of zł4.50 is trading 4.4% above its estimated GF Value™ of zł4.31.
GuruFocus considers Massmedica to be Fairly Valued.
Key valuation signals for WAR:MSM:
Days Payable: 164.76 (23% below median its 10-year median of 213.27)
GF Value™: zł4.31 vs. price of zł4.50 (4.4% above fair value)
Industry Position: 142.8% above the Medical Devices & Instruments median (#162 of 795)
No single metric tells the full story. See the WAR:MSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Massmedica SA is operating in the areas of reconstructive, regenerative, anti-aging and aesthetic medicine. It deals in the distribution of implants and other medical materials used in the treatment of diseases of the musculoskeletal system and in regenerative medicine.
84GF Score
Get the complete analysis for WAR:MSM
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MSM has been successfully added to your 
